Editorial Board — Medscape Nephrology

Board Members

 

Board Member Details

Rajiv Agarwal, MD
Rajiv Agarwal, MD

Professor of Medicine, Indiana University School of Medicine; Staff Physician, Indiana University, Indianapolis, Indiana

Rajiv Agarwal, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Akebia Therapeutics; Relypsa Inc; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Opko; sanofi-aventis; AstraZeneca Pharmaceuticals LP; Amgen Inc.

Received income in an amount equal to or greater than $250 from: Akebia Therapeutics; Relypsa Inc; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Opko; sanofi-aventis; AstraZeneca Pharmaceuticals LP; Amgen Inc.

Jeffrey S. Berns, MD
Jeffrey S. Berns, MD

Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Director, Nephrology Fellowship Training Program, Renal, Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia; Associate Dean for Graduate Medical Education, University of Pennsylvania Health System, Philadelphia, Pennsylvania; Editor-in-Chief, Medscape Nephrology

Jeffrey S. Berns, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for:
National Kidney Foundation; Amgen Inc.; Bayer HealthCare Pharmaceuticals
Received income in an amount equal to or greater than $250 from:
American Board of Internal Medicine; UpToDate

Francesco Locatelli, MD

Professor, Scientific Director, Department of Nephrology, Alessandro Manzoni Hospital, Lecco, Italy

Francesco Locatelli, MD, has disclosed the following relevant financial relationships:
Serve(d) as an advisor for: Akebia Therapeutics; Amgen Inc.; Astellas Pharma, Inc.
Serve(d) as a speaker for: Amgen Inc.; Asahi Kasei Corporation; Astellas Pharma, Inc.; B. Braun Medical Inc.; Menarini Group; Roche; Vifor Pharma; Fresenius SE & Co. KGaA

Donal J. O'Donoghue, MBChB, FRCP
Donal O'Donoghue, MB, ChB

Professor, University of Manchester; Consultant Renal Physician, Salford Royal NHS Foundation Trust, Manchester, United Kingdom

Donal J. O'Donoghue, MBChB, FRCP, has disclosed no relevant financial relationships.

Richard A. Sherman, MD
Richard A. Sherman, MD

Professor Emeritus, Robert Wood Johnson Medical School, New Brunswick, New Jersey

Richard A. Sherman, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Merck & Co. Inc.

Lynda A. Szczech, MD, MSE
Lynda A. Szczech, MD

Nephrologist, Durham Nephrology Associates, Durham, North Carolina

Lynda Szczech, MD, MSE, has disclosed the following relevant financial relationship:
Employee of: FibroGen

Matthew R. Weir, MD
Matthew R. Weir, MD

Professor of Medicine; Director, Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland

Matthew R. Weir, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Merck Sharp & Dohme Corp.; sanofi-aventis; Relypsa, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Boston Scientific; Akebia Therapeutics

Received income in an amount equal to or greater than $250 from: Merck Sharp & Dohme Corp.; sanofi-aventis; Relypsa, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals; Boston Scientific; Akebia Therapeutics